Synchron’s brain-computer interface tech meets safety goal

MedTech Dive October 1, 2024
Nick Paul Taylor

Synchron also reported evidence the device worked in the six-patient trial, with the conversion of brain signals to motor outputs allowing people to perform digital tasks.

Dive Brief:

• Synchron’s brain computer interface (BCI) device caused no deaths or permanent increases in disability in the first year of a U.S. clinical trial, the company said Monday.
• The study enrolled six people with severe chronic bilateral upper-limb paralysis unresponsive to therapy to receive the device. The absence of device-related death or disability caused the trial to meet its primary endpoint.
• Synchron also reported evidence the technology consistently worked in participants, with the conversion of brain signals to motor outputs allowing people to perform digital tasks. The median deployment for the device...

Today's Sponsors

Today's Sponsor